Search research articles
Contact Us
Filters
Showing results (31-40 of 58) with videos related to
Page
of 6
Sort By:
Pharmacoepidemiology and Drug Safety
|
February 14, 2008
Risk factors for nonadherence to warfarin: results from the IN-RANGE study
Alec B Platt, A Russell Localio, Colleen M Brensinger, et al.
Chest
|
November 12, 2009
Can we predict daily adherence to warfarin?: Results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study
Alec B Platt, A Russell Localio, Colleen M Brensinger, et al.
Open Forum Infectious Diseases
|
September 29, 2025
Changes in Bone Microarchitecture and Inflammatory Cytokines After Cure of Chronic Hepatitis C Infection With Direct-Acting Antiviral Therapy
Vincent Lo Re, Dean M Carbonari, Craig W Newcomb, et al.
Open Forum Infectious Diseases
|
April 30, 2025
Abnormal Trabecular and Cortical Bone Microarchitecture in Chronic Hepatitis C Infection and Associations With Select Inflammatory Cytokines
Erica J Weinstein, Dean M Carbonari, Craig W Newcomb, et al.
Annals of Internal Medicine
|
August 4, 2010
Weight and metabolic outcomes after 2 years on a low-carbohydrate versus low-fat diet: a randomized trial
Gary D Foster, Holly R Wyatt, James O Hill, et al.
Journal of Hepatology
|
August 1, 2021
Protease inhibitor-based direct-acting antivirals are associated with increased risk of aminotransferase elevations but not hepatic dysfunction or decompensation
Jessie Torgersen, Craig W Newcomb, Dean M Carbonari, et al.
The Journal of Urology
|
October 7, 2020
Association of Longitudinal Changes in Symptoms and Urinary Biomarkers in Patients with Urological Chronic Pelvic Pain Syndrome: A MAPP Research Network Study
Roopali Roy, Alisa J Stephens, Cassandra Daisy, et al.
American Journal of Ophthalmology
|
January 17, 2016
Remission of Intermediate Uveitis: Incidence and Predictive Factors
John H Kempen, Dina Y Gewaily, Craig W Newcomb, et al.
Pharmacoepidemiology and Drug Safety
|
December 11, 2024
Hepatotoxicity Score: A New Method to Adjust for Use of Potentially Hepatotoxic Medications by Chronic Liver Disease Status
Vincent Lo Re, Craig W Newcomb, Dean M Carbonari, et al.
Ophthalmology
|
December 22, 2015
Risk of Retinal Neovascularization in Cases of Uveitis
Apurva K Patel, Craig W Newcomb, Teresa L Liesegang, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 58) with videos related to
Sort By:
Page
of 6
Pharmacoepidemiology and Drug Safety
|
February 14, 2008
Risk factors for nonadherence to warfarin: results from the IN-RANGE study
Alec B Platt, A Russell Localio, Colleen M Brensinger, et al.
Chest
|
November 12, 2009
Can we predict daily adherence to warfarin?: Results from the International Normalized Ratio Adherence and Genetics (IN-RANGE) Study
Alec B Platt, A Russell Localio, Colleen M Brensinger, et al.
Open Forum Infectious Diseases
|
September 29, 2025
Changes in Bone Microarchitecture and Inflammatory Cytokines After Cure of Chronic Hepatitis C Infection With Direct-Acting Antiviral Therapy
Vincent Lo Re, Dean M Carbonari, Craig W Newcomb, et al.
Open Forum Infectious Diseases
|
April 30, 2025
Abnormal Trabecular and Cortical Bone Microarchitecture in Chronic Hepatitis C Infection and Associations With Select Inflammatory Cytokines
Erica J Weinstein, Dean M Carbonari, Craig W Newcomb, et al.
Annals of Internal Medicine
|
August 4, 2010
Weight and metabolic outcomes after 2 years on a low-carbohydrate versus low-fat diet: a randomized trial
Gary D Foster, Holly R Wyatt, James O Hill, et al.
Journal of Hepatology
|
August 1, 2021
Protease inhibitor-based direct-acting antivirals are associated with increased risk of aminotransferase elevations but not hepatic dysfunction or decompensation
Jessie Torgersen, Craig W Newcomb, Dean M Carbonari, et al.
The Journal of Urology
|
October 7, 2020
Association of Longitudinal Changes in Symptoms and Urinary Biomarkers in Patients with Urological Chronic Pelvic Pain Syndrome: A MAPP Research Network Study
Roopali Roy, Alisa J Stephens, Cassandra Daisy, et al.
American Journal of Ophthalmology
|
January 17, 2016
Remission of Intermediate Uveitis: Incidence and Predictive Factors
John H Kempen, Dina Y Gewaily, Craig W Newcomb, et al.
Pharmacoepidemiology and Drug Safety
|
December 11, 2024
Hepatotoxicity Score: A New Method to Adjust for Use of Potentially Hepatotoxic Medications by Chronic Liver Disease Status
Vincent Lo Re, Craig W Newcomb, Dean M Carbonari, et al.
Ophthalmology
|
December 22, 2015
Risk of Retinal Neovascularization in Cases of Uveitis
Apurva K Patel, Craig W Newcomb, Teresa L Liesegang, et al.
Page
of 6